Clario Executive and Leadership Team

August, 2026

Leadership Overview

Clario has 10 executives leading key functions including strategy, technology, operations, finance, revenue, medical oversight, and legal affairs.

Focused on delivering advanced endpoint technology for clinical trials, Clario empowers pharmaceutical and medical device partners to generate high-quality clinical evidence through a comprehensive, global platform that transforms patient lives.

Leadership Roles at Clario

  • President & Chief Executive Officer - Nate Goldenman
  • President & Chief Executive Officer - Christopher Fikry
  • Chief Executive Officer & Founder - Joshua Collins
  • Chief Financial Officer, Rei Bookkeeping & Fractional Services - Alexander Brito
  • Chief Operating Officer - Nayan Nanavati
  • Chief Operating Officer & Senior VP - Angelo Stortini
  • Chief Technology Officer - Douglas Cory
  • Senior Commercial Director - Strategic Chief Revenue Officer Partnerships - Matthew Borer
  • Chief Medical Officer - Todd Rudo
  • Executive Vice President & Chief Legal Officer - Eric Schwartz
  • Nate Goldenman - President & Chief Executive Officer

    Nate Goldenman, the President & Chief Executive Officer at Clario, directs the overarching corporate strategy to advance endpoint technology solutions for global clinical trials. Goldenman architects the long-term vision for the organization, ensuring that scientific expertise integrates seamlessly with the company's comprehensive technology platform. By overseeing the expansion of decentralized and hybrid trial models, the President & Chief Executive Officer drives market adoption across North America and international territories. This leadership role involves constant collaboration with the Board to maintain regulatory excellence and operational efficiency. Nate Goldenman directly influences the company's ability to support pharmaceutical and biotechnology partners in achieving critical trial milestones. Through rigorous focus on innovation and scalability, the President & Chief Executive Officer secures the firm's position as a leader in clinical evidence generation, ultimately fostering growth and delivering value to stakeholders while maintaining the highest standards of data integrity.

    Christopher Fikry - President & Chief Executive Officer

    Christopher Fikry, the President & Chief Executive Officer at Clario, manages the execution of the company's mission to transform lives through superior clinical trial technology. Fikry focuses on the operational integration of the Trial Anywhere approach, ensuring that site-based and decentralized models deliver rich, reliable clinical evidence. The President & Chief Executive Officer oversees the alignment of global resources across Europe and the Asia Pacific region to meet the complex needs of medical device partners. By prioritizing the synthesis of technology and science, the President & Chief Executive Officer drives the development of robust platforms that simplify regulatory approval processes. Christopher Fikry maintains a sharp focus on market competitiveness, ensuring that the organization remains at the forefront of the industry. Through strategic oversight of internal processes, the President & Chief Executive Officer guarantees that the company consistently meets the evolving demands of the global healthcare landscape.

    Joshua Collins - Chief Executive Officer & Founder

    Joshua Collins, the Chief Executive Officer & Founder at Clario, establishes the foundational principles that guide the development of endpoint technology for clinical research. Collins drives the company's commitment to scientific rigor and technological innovation, ensuring that every solution supports the successful delivery of clinical trials. The Chief Executive Officer & Founder oversees the strategic direction of the firm, fostering a culture that prioritizes patient outcomes and regulatory success. By championing the Trial Anywhere methodology, the Chief Executive Officer & Founder enables partners to navigate complex trial environments with confidence. Joshua Collins maintains deep engagement with industry leaders to anticipate future trends in biotechnology and pharmaceutical research. Through this visionary leadership, the Chief Executive Officer & Founder ensures that the organization remains agile and responsive to the needs of global clinical research teams, consistently delivering high-quality evidence that accelerates the path to regulatory approval.

    Alexander Brito - Chief Financial Officer, Rei Bookkeeping & Fractional Services

    Alexander Brito, the Chief Financial Officer, Rei Bookkeeping & Fractional Services at Clario, directs the financial strategy and fiscal health of the organization. Brito oversees the management of capital allocation, budgeting, and financial reporting to ensure the company maintains a strong position in the competitive clinical trial market. The Chief Financial Officer, Rei Bookkeeping & Fractional Services drives the implementation of robust bookkeeping practices and fractional service models that enhance operational transparency. By analyzing financial data, the Chief Financial Officer, Rei Bookkeeping & Fractional Services supports the executive team in making informed decisions regarding investments in technology and global expansion. Alexander Brito ensures that all financial operations comply with international standards, providing the stability necessary for the company to pursue its mission of transforming lives. Through meticulous financial oversight, the Chief Financial Officer, Rei Bookkeeping & Fractional Services secures the resources required to sustain the firm's leadership in endpoint technology and clinical evidence generation.

    Nayan Nanavati - Chief Operating Officer

    Nayan Nanavati, the Chief Operating Officer at Clario, manages the internal processes and operational workflows that sustain the company's global clinical trial services. Nanavati directs the execution of service delivery, ensuring that all operational teams maintain the highest standards of quality and efficiency. The Chief Operating Officer oversees the integration of scientific expertise into daily operations, supporting the successful deployment of the Trial Anywhere approach. By optimizing resource allocation across North America and international regions, the Chief Operating Officer drives productivity and operational excellence. Nayan Nanavati works closely with the executive team to streamline cross-functional collaboration and improve service delivery timelines. This leadership role involves monitoring key performance indicators to ensure that the organization meets the rigorous demands of biotechnology and medical device partners. Through disciplined operational management, the Chief Operating Officer ensures that the company consistently delivers reliable clinical evidence while maintaining a focus on long-term scalability and growth.

    Angelo Stortini - Chief Operating Officer & Senior VP

    Angelo Stortini, the Chief Operating Officer & Senior VP at Clario, oversees the strategic scaling of the company's operational infrastructure to support global clinical trial demands. Stortini directs the implementation of standardized processes that enhance the efficiency of site-based and decentralized trial models. The Chief Operating Officer & Senior VP manages the coordination between technology teams and operational staff to ensure the seamless delivery of endpoint solutions. By focusing on process optimization and quality assurance, the Chief Operating Officer & Senior VP drives the company's ability to handle large-scale, complex clinical studies across diverse geographic regions. Angelo Stortini collaborates with other senior leaders to align operational capacity with the evolving needs of pharmaceutical and biotechnology partners. This leadership role involves fostering a culture of continuous improvement and operational excellence. Through strategic oversight, the Chief Operating Officer & Senior VP ensures that the organization maintains its reputation for delivering high-quality clinical evidence with precision and speed.

    Douglas Cory - Chief Technology Officer

    Douglas Cory, the Chief Technology Officer at Clario, architects the digital infrastructure that powers the company's endpoint technology platform. Cory directs the engineering and development teams to ensure that all software solutions meet the stringent requirements of global clinical trials. The Chief Technology Officer oversees the implementation of secure, scalable systems that support decentralized and hybrid trial models across diverse geographic markets. By integrating advanced data analytics and cloud-based tools, the Chief Technology Officer drives the continuous improvement of the platform's performance and reliability. Douglas Cory collaborates with other C-suite leaders to align technological capabilities with the broader strategic goals of the organization. This leadership role involves managing the lifecycle of complex software products to ensure compliance with international regulatory standards. Through technical innovation, the Chief Technology Officer enables the company to provide seamless, high-quality evidence generation for pharmaceutical and medical device partners worldwide.

    Matthew Borer - Senior Commercial Director - Strategic Chief Revenue Officer Partnerships

    Matthew Borer, the Senior Commercial Director - Strategic Chief Revenue Officer Partnerships at Clario, directs the development of high-value commercial relationships that drive revenue growth. Borer architects strategic partnerships with key pharmaceutical and biotechnology firms to expand the reach of the company's endpoint technology platform. The Senior Commercial Director - Strategic Chief Revenue Officer Partnerships oversees the alignment of commercial strategies with the company's broader mission of delivering high-quality clinical evidence. By identifying new market opportunities across North America and international territories, the Senior Commercial Director - Strategic Chief Revenue Officer Partnerships drives the acquisition of new business and the retention of existing partners. Matthew Borer collaborates with the executive team to refine the value proposition and ensure that commercial efforts support the company's long-term financial objectives. Through proactive engagement and strategic planning, the Senior Commercial Director - Strategic Chief Revenue Officer Partnerships secures the firm's market position and fosters sustainable revenue streams.

    Todd Rudo - Chief Medical Officer

    Todd Rudo, the Chief Medical Officer at Clario, directs the scientific and medical strategy that underpins the company's endpoint technology solutions. Rudo oversees the clinical integrity of the platform, ensuring that all data collection and analysis methods meet the highest regulatory standards. The Chief Medical Officer provides expert guidance on the design and execution of clinical trials, supporting partners in navigating complex medical and scientific challenges. By integrating clinical expertise into the development of technology, the Chief Medical Officer drives the creation of solutions that generate reliable, high-quality evidence. Todd Rudo collaborates with the executive team to ensure that the company's offerings remain aligned with the latest advancements in medical research and regulatory requirements. This leadership role involves representing the firm in scientific forums and engaging with regulatory bodies to advocate for innovative trial methodologies. Through medical leadership, the Chief Medical Officer ensures that the company consistently delivers evidence that transforms patient lives.
    Todd Rudo
    Eric Schwartz, the Executive Vice President & Chief Legal Officer at Clario, directs the legal and compliance framework that governs the company's global operations. Schwartz oversees the management of intellectual property, regulatory compliance, and contractual obligations to protect the firm's interests in the clinical trial market. The Executive Vice President & Chief Legal Officer ensures that all technology solutions and trial models adhere to international legal standards and data privacy regulations. By providing strategic legal counsel, the Executive Vice President & Chief Legal Officer supports the executive team in navigating complex business transactions and partnerships. Eric Schwartz manages the legal risks associated with global expansion, ensuring that the company operates with integrity and transparency across all regions. This leadership role involves close collaboration with the Board and other C-suite leaders to maintain a robust governance structure. Through legal oversight, the Executive Vice President & Chief Legal Officer enables the company to innovate safely and effectively.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Clario Top Executives and Leadership Team

    Who leads Clario?
    Clario is led by Nate Goldenman (President & Chief Executive Officer), along with executives such as Christopher Fikry (President & Chief Executive Officer) and Joshua Collins (Chief Executive Officer & Founder).
    Who is part of Clario’s executive team?
    The executive team of Clario includes leaders such as Nate Goldenman (President & Chief Executive Officer), Christopher Fikry (President & Chief Executive Officer), Joshua Collins (Chief Executive Officer & Founder) and other senior executives.
    How many executives does Clario have?
    Clario has 10 executives leading key business areas.
    What roles are included in Clario’s leadership team?
    The leadership team of Clario includes roles such as President & Chief Executive Officer, President & Chief Executive Officer, Chief Executive Officer & Founder, Chief Financial Officer, Rei Bookkeeping & Fractional Services, Chief Operating Officer.